Evaluation of myocardial functional parameters during intravenous cyclophosphamide pulse therapy: A case report

Multiple Sclerosis

Volumn 8, Issue 2, 2002, Pages 179-

  Merico, Antonio ^a   Levedianos, Giorgio ^a   Gallo, Paolo ^b   Zanco, Pierliugi ^c   Piccione, Francesco ^a   Tonin, Paolo ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Division of Nuclear Medicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PROPRANOLOL; STEROID; THIAMAZOLE;

ADULT; AUTOIMMUNE DISEASE; CARDIOVASCULAR RISK; CASE REPORT; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; DYSPNEA; HEART DISEASE; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART VENTRICLE FUNCTION; HUMAN; HYPERTHYROIDISM; LETTER; MALE; MULTIPLE SCLEROSIS; SINUS TACHYCARDIA;

ANTITHYROID AGENTS; AUTOIMMUNE DISEASES; BACLOFEN; CYCLOPHOSPHAMIDE; HEART; HUMANS; HYPERTHYROIDISM; IMMUNOSUPPRESSIVE AGENTS; MALE; METHIMAZOLE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; STROKE VOLUME; TACHYCARDIA, SINUS;

EID: 18344371158     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms774xx     Document Type: Letter

References (7)

1. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
2. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: Final report of Northeast Cooperative Multiple Sclerosis Treatment Group
3. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis
4. Side-effects of intravenous cyclophosphamide pulse therapy
5. Chemotherapy and cardiotoxicity
6. Cardiotoxicity of chemotherapeutic agents: Incidence, treatment and prevention
7. Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer